Home
Stocks
Sanofi looks to accelerate MS treatment with $3.68 billion acquisition of Principia Biopharma
Stocks

Sanofi looks to accelerate MS treatment with $3.68 billion acquisition of Principia Biopharma

4 years ago No Comments

This post was originally published on this site

Sanofi Chief Executive Paul Hudson strikes his second biotech deal since taking over at the French drugmaker last year.

Related Posts

About The Author

admin
More from this Author

Add Comment